Creation of Functional Molecules Based on Biomolecular Interactions; Development toward Chemical Biology
Author:
- 1 October 2017
- journal article
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 137 (10) , 1223-1231
Abstract
Interactions between bio-macromolecules such as proteins, DNA, and polysaccharides play pivotal roles in maintaining homeostasis in living systems. For elucidating the function of biomolecules, peptides are powerful tools, compared to native proteins, because of their lower molecular weights, compatibility with chemical modification, and predictability of interaction with the target molecules. These advantages enabled us to develop peptide-based functional molecules. However, for the purposes of controlling or regulating biomolecule functions, designing artificial proteins is also an effective approach. Not only rational protein design, but also directed molecular evolution, are now regarded as powerful methods for optimizing protein function. The interactions of proteins with bio-macromolecules are usually highly specific and show high affinity because of larger interaction surfaces as compared to small molecules or peptides. Thus, the use of proteins for designing biofunctional molecules is also important for wider applications in the biotechnology field. In this review, four topics will be discussed: 1) the development of fluorescently-labeled ligands for G protein-coupled receptors (GPCR), as well as bivalent ligands for GPCR imaging and function analysis, 2) the design and synthesis of gp41 trimer mimics as HIV-1 inhibitors or vaccines, 3) the development of a ZIP tag-probe system and its application to intracellular protein imaging, and 4) the functional analysis of sequence-specific DNA recombinase for expanding the scope of genome editing. The results of these studies indicate the importance of precision in the design of peptides or proteins for regulating bio-macromolecular interactions.Keywords
This publication has 17 references indexed in Scilit:
- Peptide-tags for site-specific protein labelling in vitro and in vivoMolecular BioSystems, 2016
- Multimerized CHR-derived peptides as HIV-1 fusion inhibitorsBioorganic & Medicinal Chemistry, 2013
- Evaluation of a synthetic C34 trimer of HIV-1 gp41 as AIDS vaccinesBioorganic & Medicinal Chemistry, 2012
- A Synthetic C34 Trimer of HIV‐1 gp41 Shows Significant Increase in Inhibition PotencyChemMedChem, 2012
- Bivalent Ligands of CXCR4 with Rigid Linkers for Elucidation of the Dimerization State in CellsJournal of the American Chemical Society, 2010
- Remodeling of Dynamic Structures of HIV-1 Envelope Proteins Leads to Synthetic Antigen Molecules Inducing Neutralizing AntibodiesBioconjugate Chemistry, 2010
- Fluorophore Labeling Enables Imaging and Evaluation of Specific CXCR4−Ligand Interaction at the Cell Membrane for Fluorescence-Based ScreeningBioconjugate Chemistry, 2008
- Molecular‐Size Reduction of a Potent CXCR4‐Chemokine Antagonist Using Orthogonal Combination of Conformation‐ and Sequence‐Based LibrariesAngewandte Chemie International Edition, 2003
- Remodeling of gp41-C34 Peptide Leads to Highly Effective Inhibitors of the Fusion of HIV-1 with Target Cells We thank Dr. Terrence R. Burke, Jr., NCI, NIH, Frederick, MD 21702-1201, for proofreading the manuscript and providing useful comments. This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Japan Society for the Promotion of Science, and the Japan Health Science Foundation.Angewandte Chemie International Edition, 2002
- A Low-Molecular-Weight Inhibitor against the Chemokine Receptor CXCR4: A Strong Anti-HIV Peptide T140Biochemical and Biophysical Research Communications, 1998